Literature DB >> 23649623

HMGB1 protein does not mediate the inflammatory response in spontaneous spinal cord regeneration: a hint for CNS regeneration.

Yingying Dong1, Yun Gu, Youjuan Huan, Yingjie Wang, Yan Liu, Mei Liu, Fei Ding, Xiaosong Gu, Yongjun Wang.   

Abstract

Uncontrolled, excessive inflammation contributes to the secondary tissue damage of traumatic spinal cord, and HMGB1 is highlighted for initiation of a vicious self-propagating inflammatory circle by release from necrotic cells or immune cells. Several regenerative-competent vertebrates have evolved to circumvent the second damages during the spontaneous spinal cord regeneration with an unknown HMGB1 regulatory mechanism. By genomic surveys, we have revealed that two paralogs of HMGB1 are broadly retained from fish in the phylogeny. However, their spatial-temporal expression and effects, as shown in lowest amniote gecko, were tightly controlled in order that limited inflammation was produced in spontaneous regeneration. Two paralogs from gecko HMGB1 (gHMGB1) yielded distinct injury and infectious responses, with gHMGB1b significantly up-regulated in the injured cord. The intracellular gHMGB1b induced less release of inflammatory cytokines than gHMGB1a in macrophages, and the effects could be shifted by exchanging one amino acid in the inflammatory domain. Both intracellular proteins were able to mediate neuronal programmed apoptosis, which has been indicated to produce negligible inflammatory responses. In vivo studies demonstrated that the extracellular proteins could not trigger a cascade of the inflammatory cytokines in the injured spinal cord. Signal transduction analysis found that gHMGB1 proteins could not bind with cell surface receptors TLR2 and TLR4 to activate inflammatory signaling pathway. However, they were able to interact with the receptor for advanced glycation end products to potentiate oligodendrocyte migration by activation of both NFκB and Rac1/Cdc42 signaling. Our results reveal that HMGB1 does not mediate the inflammatory response in spontaneous spinal cord regeneration, but it promotes CNS regeneration.

Entities:  

Keywords:  CNS; Evolution; HMGB1; Inflammation; Receptor for Advanced Glycation End Products (RAGE); Regeneration; Toll-like receptors (TLR)

Mesh:

Substances:

Year:  2013        PMID: 23649623      PMCID: PMC3689963          DOI: 10.1074/jbc.M113.463810

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Flexing DNA: HMG-box proteins and their partners.

Authors:  M E Bianchi; M Beltrame
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

3.  Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.

Authors:  H J Huttunen; C Fages; H Rauvala
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

4.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

5.  Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.

Authors:  M T Fitch; C Doller; C K Combs; G E Landreth; J Silver
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 6.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

Review 7.  Genome evolution and biodiversity in teleost fish.

Authors:  J-N Volff
Journal:  Heredity (Edinb)       Date:  2005-03       Impact factor: 3.821

8.  Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.

Authors:  Ingrid E Dumitriu; Paramita Baruah; Barbara Valentinis; Reinhard E Voll; Martin Herrmann; Peter P Nawroth; Bernd Arnold; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

9.  RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.

Authors:  R Kokkola; A Andersson; G Mullins; T Ostberg; C-J Treutiger; B Arnold; P Nawroth; U Andersson; R A Harris; H E Harris
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

10.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.

Authors:  Allan Tsung; Rohit Sahai; Hiroyuki Tanaka; Atsunori Nakao; Mitchell P Fink; Michael T Lotze; Huan Yang; Jianhua Li; Kevin J Tracey; David A Geller; Timothy R Billiar
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

View more
  20 in total

1.  Receptor for Advanced Glycation End-Products (RAGE) Blockade Do Damage to Neuronal Survival via Disrupting Wnt/β-Catenin Signaling in Spinal Cord Injury.

Authors:  Hongyu Wang; Ziming Zhao; Chang Liu; Zhanpeng Guo; Yajiang Yuan; Haoshen Zhao; Zipeng Zhou; Xifan Mei
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

2.  PGE2 facilitates tail regeneration via activation of Wnt signaling in Gekko japonicus.

Authors:  Man Xu; Tiantian Wang; Wenjuan Li; Yin Wang; Yanran Xu; Zuming Mao; Ronghua Wu; Mei Liu; Yan Liu
Journal:  J Mol Histol       Date:  2019-09-18       Impact factor: 2.611

3.  Axonal amphoterin mRNA is regulated by translational control and enhances axon outgrowth.

Authors:  Tanuja T Merianda; Jennifer Coleman; Hak Hee Kim; Pabitra Kumar Sahoo; Cynthia Gomes; Paul Brito-Vargas; Heikki Rauvala; Armin Blesch; Soonmoon Yoo; Jeffery L Twiss
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

4.  High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation.

Authors:  Kristina A Kigerl; Wenmin Lai; Lindsay M Wallace; Huan Yang; Phillip G Popovich
Journal:  Brain Behav Immun       Date:  2017-11-23       Impact factor: 7.217

Review 5.  Dealing with Danger in the CNS: The Response of the Immune System to Injury.

Authors:  Sachin P Gadani; James T Walsh; John R Lukens; Jonathan Kipnis
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

6.  High-mobility group box-1 as an autocrine trophic factor in white matter stroke.

Authors:  Jun Young Choi; Yuexian Cui; Samma Tasneem Chowdhury; Byung Gon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

7.  Autologous serum supplement favours in vitro regenerative paracrine factors synthesis.

Authors:  Nazmul Haque; Noor Hayaty Abu Kasim; Noor Lide Abu Kassim; Mohammad Tariqur Rahman
Journal:  Cell Prolif       Date:  2017-07-06       Impact factor: 6.831

8.  HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Authors:  Bilon Khambu; Nazmul Huda; Xiaoyun Chen; Daniel J Antoine; Yong Li; Guoli Dai; Ulrike A Köhler; Wei-Xing Zong; Satoshi Waguri; Sabine Werner; Tim D Oury; Zheng Dong; Xiao-Ming Yin
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

9.  The regenerating spinal cord of gecko maintains unaltered expression of β-catenin following tail amputation.

Authors:  Honghua Song; Lili Man; Yingjie Wang; Xue Bai; Sumei Wei; Yan Liu; Mei Liu; Xiaosong Gu; Yongjun Wang
Journal:  J Mol Neurosci       Date:  2014-09-02       Impact factor: 3.444

Review 10.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.